These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15842882)

  • 1. [Advances in biomarkers of oral premalignant lesions: a review].
    Ge SY; Zhou ZT
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Mar; 40(2):166-8. PubMed ID: 15842882
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 expression in oral disease.
    Ogden GR
    Br J Oral Maxillofac Surg; 1993 Feb; 31(1):63. PubMed ID: 8431418
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular genetics of premalignant oral lesions.
    Mithani SK; Mydlarz WK; Grumbine FL; Smith IM; Califano JA
    Oral Dis; 2007 Mar; 13(2):126-33. PubMed ID: 17305612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Loss of heterozygosity as a tool in the evaluation of cancer risk in premalignant lesions of the head and neck].
    Soria JC
    Bull Cancer; 2000 Jun; 87(6):446. PubMed ID: 10903785
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral cancer prevention and the evolution of molecular-targeted drug development.
    Lippman SM; Sudbø J; Hong WK
    J Clin Oncol; 2005 Jan; 23(2):346-56. PubMed ID: 15637397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A treatment for oral precancerous lesions: why do we not yet have a treatment?
    Lozada-Nur F
    Med Oral Patol Oral Cir Bucal; 2009 Apr; 14(4):E159-62. PubMed ID: 19333182
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of nuclear morphometry and DNA ploidy status for detection of malignant and premalignant oral lesions: quantitative cytologic assessment and review of methods for cytomorphometric measurements.
    Pektas ZO; Keskin A; Günhan O; Karslioğlu Y
    J Oral Maxillofac Surg; 2006 Apr; 64(4):628-35. PubMed ID: 16546642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on molecular pathology in oral cancer and precancer.
    Campo-Trapero J; Cano-Sánchez J; Palacios-Sánchez B; Sánchez-Gutierrez JJ; González-Moles MA; Bascones-Martínez A
    Anticancer Res; 2008; 28(2B):1197-205. PubMed ID: 18505056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers and histology of premalignant and malignant lesions.
    Beltrami AC; Puglisi F; Di Lauro V; Scalone S; Amoroso V; Bonura S; Stamerra O; Raiti C; Di Loreto C
    Eur J Cancer Prev; 1996 Oct; 5(5):375-6. PubMed ID: 8972261
    [No Abstract]   [Full Text] [Related]  

  • 12. Disease mechanism and biomarkers of oral squamous cell carcinoma.
    Brinkman BM; Wong DT
    Curr Opin Oncol; 2006 May; 18(3):228-33. PubMed ID: 16552233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin A activity predicts clinical outcome in oral precancer and cancer.
    Thomson PJ; Goodson ML; Booth C; Cragg N; Hamadah O
    Int J Oral Maxillofac Surg; 2006 Nov; 35(11):1041-6. PubMed ID: 16962288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p16(INK4a) promoter hypermethylation in oral scrapings of oral squamous cell carcinoma risk patients.
    Ruesga MT; Acha-Sagredo A; Rodríguez MJ; Aguirregaviria JI; Videgain J; Rodríguez C; de Pancorbo Mde L; Aguirre JM
    Cancer Lett; 2007 May; 250(1):140-5. PubMed ID: 17113222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting recurrence after oral precancer treatment: use of cell cycle analysis.
    Thomson PJ; Hamadah O; Goodson ML; Cragg N; Booth C
    Br J Oral Maxillofac Surg; 2008 Jul; 46(5):370-5. PubMed ID: 18282643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markers predicting oral lesion progression identified, say researchers.
    J Am Dent Assoc; 2012 Oct; 143(10):1082-3. PubMed ID: 23193642
    [No Abstract]   [Full Text] [Related]  

  • 17. Nucleotide excision repair pathway genes and oral premalignant lesions.
    Wang Y; Spitz MR; Lee JJ; Huang M; Lippman SM; Wu X
    Clin Cancer Res; 2007 Jun; 13(12):3753-8. PubMed ID: 17575242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue markers of potentially malignant human oral epithelial lesions.
    Scully C; Burkhardt A
    J Oral Pathol Med; 1993 Jul; 22(6):246-56. PubMed ID: 8355223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: continuing research and implications for clinical practice.
    Epstein JB; Sciubba J; Silverman S; Sroussi HY
    Head Neck; 2007 Oct; 29(10):948-58. PubMed ID: 17764090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopsy and histopathologic diagnosis of oral premalignant and malignant lesions.
    Poh CF; Ng S; Berean KW; Williams PM; Rosin MP; Zhang L
    J Can Dent Assoc; 2008 Apr; 74(3):283-8. PubMed ID: 18387269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.